Tumor-Associated Exosomes: A Potential Therapeutic Target for Restoring Anti-Tumor T Cell Responses in Human Tumor Microenvironments

por Shenoy, Gautam N., Bhatta, Maulasri, Bankert, Richard B.
Publicado 2021

Rational design of a nanoparticle platform for oral prophylactic immunotherapy to prevent immunogenicity of therapeutic proteins

por Nguyen, Nhan H., Glassman, Fiona Y., Dingman, Robert K., Shenoy, Gautam N., Wohlfert, Elizabeth A., Kay, Jason G., Bankert, Richard B., Balu-Iyer, Sathy V.
Publicado 2021

Preclinical evaluation of cancer immune therapy using patient‐derived tumor antigen‐specific T cells in a novel xenograft platform

por Shenoy, Gautam N, Greene, Christopher J, Bhatta, Maulasri, Baroja, Miren L, Loyall, Jenni L, Balu‐Iyer, Sathy V, Kelleher, Raymond J, Carreno, Beatriz M, Linette, Gerald P, Shultz, Leonard D, Bankert, Richard B
Publicado 2021

Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironments

por Bhatta, Maulasri, Shenoy, Gautam N, Loyall, Jenni L, Gray, Brian D, Bapardekar, Meghana, Conway, Alexis, Minderman, Hans, Kelleher Jr, Raymond J, Carreno, Beatriz M, Linette, Gerald, Shultz, Leonard D, Odunsi, Kunle, Balu-Iyer, Sathy V, Pak, Koon Yan, Bankert, Richard B
Publicado 2021